Announced
Completed
Financials
Sources
Tags
Acquisition
Friendly
Domestic
Majority
Private
Completed
United States
medical laboratory
Single Bidder
Biotechnology
Synopsis
Natera, a clinical genetic testing company, completed the acquisition of reproductive health assets from Invitae, a biotechnology company. Financial terms were not disclosed. “We are committed to providing excellent service, and we look forward to the opportunity to support additional patients and providers,” Steve Chapman, Natera CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.